Doping-WADA outlaws tramadol use from 2024, maintains cannabis ban By Reuters
World 43 minutes ago (Sep 23, 2022 03:46AM ET)
SYDNEY (Reuters) – The World Anti-Doping Agency will add the painkiller tramadol to the list of banned substances for athletes in competition from 2024 and has maintained its ban on cannabis after a review.
The decisions were taken by WADA’s executive committee after a meeting in Sydney on Friday and followed recommendations from the body’s advisory group on the list of banned substances.
“Tramadol abuse, with its dose-dependent risks of physical dependence, opiate addiction and overdoses in the general population, is of concern and has led to it being a controlled drug in many countries,” WADA said in a news release.
“Research studies funded by WADA have also confirmed the potential for tramadol to enhance physical performance.”
Former England soccer goalkeeper Chris Kirkland said in July he had been driven to the point of suicide by his addiction to, and abuse of, tramadol after using the opioid to treat back injuries.
WADA said the delay in introducing the ban until 2024 was to allow the communication of the implications of it to athletes, their entourages and medical staff.
The ban on cannabis came into focus last year when American sprinter Sha’Carri Richardson was ruled out of the Tokyo Olympics 100 metres after receiving a one-month ban for using the drug in the wake of her mother’s death.
WADA had just reduced the bans for recreational drug use by athletes who tested positive out of competition from two years down to one to three months.
After requests from some “stakeholders”, however, WADA agreed to review the cannabis ban but decided on Friday to maintain it because the use of the drug “violated the spirit of sport”.
WADA said the level of the active agent of cannabis in a sample needed to trigger a positive test in competition would require the user to be a “significantly impaired athlete or a frequent user”.
“WADA is aware of the diversity of opinions and perceptions related to this substance around the world, and even within certain countries,” director general Olivier Niggli said.
“WADA plans to continue research in this area in relation with (its) potential performance enhancing effects, its impact on the health of athletes and also in relation to perceptions of cannabis from athletes, experts and others around the world.”
Doping-WADA outlaws tramadol use from 2024, maintains cannabis ban
By Gavin Jones and Angelo Amante ROME (Reuters) – Italy’s rightist bloc led by Giorgia Meloni is strongly expected to win Sunday’s election but voter sentiment has shifted in the…
DUBAI (Reuters) -Iran’s army warned on Friday that it would “confront the enemies” to ensure security and peace in the country, according to a statement, as protests rage over the…
By Jiraporn Kuhakan BANGKOK (Reuters) – A beauty queen who spoke out against Myanmar’s military rulers was stranded at Thailand’s international airport for a third day on Friday,…
(C) 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.